• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Overcoming endocrine resistance in neoadjuvant endocrine therapy for early breast cancer.

作者信息

Jackisch Christian

机构信息

Sana Hospital Offenbach, Department of Obsterics and Gynecology and Breast Cancer Center, Offenbach, D-63069 Germany.

出版信息

Lancet Oncol. 2019 Sep;20(9):1185-1187. doi: 10.1016/S1470-2045(19)30500-5. Epub 2019 Aug 8.

DOI:10.1016/S1470-2045(19)30500-5
PMID:31402322
Abstract
摘要

相似文献

1
Overcoming endocrine resistance in neoadjuvant endocrine therapy for early breast cancer.克服早期乳腺癌新辅助内分泌治疗中的内分泌抵抗
Lancet Oncol. 2019 Sep;20(9):1185-1187. doi: 10.1016/S1470-2045(19)30500-5. Epub 2019 Aug 8.
2
Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.基础和治疗驱动的缺氧诱导因子-1α赋予雌激素受体阳性乳腺癌对内分泌治疗的抗性。
Oncotarget. 2015 Apr 20;6(11):8648-62. doi: 10.18632/oncotarget.3257.
3
[Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].来曲唑与他莫昔芬作为绝经后激素依赖性局部晚期乳腺癌患者新辅助治疗的比较
Ginecol Obstet Mex. 2011 Sep;79(9):553-7.
4
The breast cancer continuum in hormone-receptor-positive breast cancer in postmenopausal women: evolving management options focusing on aromatase inhibitors.绝经后女性激素受体阳性乳腺癌的乳腺癌连续体：聚焦芳香化酶抑制剂的不断演变的管理选择
Ann Oncol. 2008 Jan;19(1):16-27. doi: 10.1093/annonc/mdm282. Epub 2007 Aug 9.
5
Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy.来曲唑与他莫昔芬治疗晚期乳腺癌及作为新辅助治疗的比较。
J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):289-93. doi: 10.1016/s0960-0760(03)00369-8.
6
Anti-tumor effects of letrozole.来曲唑的抗肿瘤作用。
Cancer Invest. 2002;20 Suppl 2:15-21. doi: 10.1081/cnv-120014882.
7
Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer.来曲唑新辅助内分泌治疗期间与健康相关的生活质量和心理困扰，以确定绝经后乳腺癌的内分泌反应性。
Breast Cancer Res Treat. 2014 May;145(1):155-64. doi: 10.1007/s10549-014-2935-5. Epub 2014 Apr 2.
8
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.对于ErbB-1和/或ErbB-2阳性、雌激素受体阳性的原发性乳腺癌，来曲唑作为新辅助内分泌治疗比他莫昔芬更有效：一项III期随机试验的证据。
J Clin Oncol. 2001 Sep 15;19(18):3808-16. doi: 10.1200/JCO.2001.19.18.3808.
9
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.来曲唑与他莫昔芬在绝经后早期乳腺癌女性中的比较。
N Engl J Med. 2005 Dec 29;353(26):2747-57. doi: 10.1056/NEJMoa052258.
10
Letrozole in advanced breast cancer: the PO25 trial.来曲唑治疗晚期乳腺癌：PO25试验
Breast Cancer Res Treat. 2007;105 Suppl 1(Suppl 1):19-29. doi: 10.1007/s10549-007-9527-6. Epub 2007 Feb 27.

引用本文的文献

1
Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.乳腺癌患者自噬相关长链非编码RNA特征的鉴定与验证
Front Oncol. 2021 Feb 5;10:597569. doi: 10.3389/fonc.2020.597569. eCollection 2020.
2
Changes in taste and smell of food during prostate cancer treatment.前列腺癌治疗过程中食物的味觉和嗅觉变化。
Support Care Cancer. 2021 Jun;29(6):2807-2809. doi: 10.1007/s00520-021-06050-x. Epub 2021 Feb 10.
3
Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women-a literature review and proposed guidelines.
局部晚期雌激素或孕激素受体阳性乳腺癌的新辅助内分泌治疗：绝经后妇女中确定最佳内分泌药物和治疗持续时间的研究——文献综述和建议指南。
Breast Cancer Res. 2020 Jul 20;22(1):77. doi: 10.1186/s13058-020-01314-6.